跳至主要内容
临床试验/NCT05343026
NCT05343026Unknown不适用

Efficacy of Hearing-aid Treatment on Sound Perception and Residual Hearing Preservation for Patients With Tinnitus and Co-existing Hearing Loss: a Randomized Controlled Trial

Eye & ENT Hospital of Fudan University0 个研究点目标入组 62 人开始时间: 2022年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
62
主要终点
tinnitus handicap inventory (THI)

研究概览

简要总结

Considering the extent to which HAs play a role in sound perception and residual hearing preservation among patients with tinnitus and co-existing HL remains a lack of compelling extensive evidence, investigators designed this single-blind, 6-months randomized, controlled trial with two parallel groups. One is the HA treatment group, and the other is the waiting list control (WLC) group which receives no interventions during this period.

详细描述

In clinical practice, chronic subject tinnitus poses an important challenge. This condition can negatively affect an individual's emotional and functional well-being. In most cases, tinnitus is highly associated with hearing impairment, particularly in cases of high-frequency sensorineural hearing loss (SNHL). The occurrence of tinnitus in patients with HL is one of the most prevalent sensory disabilities, causing a deleterious effect on patients' lives. Nowadays, the mild to moderate SNHL can be effectively managed with a fitting hearing aid (HA) by providing sound amplification, and several findings suggest that the HA may also be helpful for people with tinnitus. Nevertheless, in terms of the effects of HA use for residual hearing protection for patients with tinnitus and co-existing hearing loss, inadequate attention is still paid by medical personnel, and relevant evidence remains preliminary at this point in time.

To assess the full extent of tinnitus patients, investigators need to carry out a series of tests, including hearing assessment and psychometric tests. Pure tone audiometry (PTA) and otoacoustic emission (OAE) tests are used to calculate the average hearing thresholds and the outer hair cell function, while the Tinnitus hazard Index (THI), the Visual Analogue Scale (VAS), the Hospital Anxiety and the Depression Scale (HADs) and the Athens Insomnia Scale-8 (AIS-8) questionnaires were for patients' psychology status.

Investigators hypothesize that in patients with tinnitus and hearing loss, HA intervention results in better conditions of tinnitus and lower hearing threshold reduction. Here investigators planned to enroll patients into two groups, the HA and non-HA (served as the control) intervention patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged older than 18 years old and less than 70 years;
  • Chronic (>6 months) subjective tinnitus, unilateral or bilateral;
  • Diagnosed with a high-frequency SNHL;
  • Be available for six months after starting the study to complete the follow-up questionnaires;
  • Readiness to participate in the study and sign the informed consent.
  • Be covered by public health insurance and eligible for reimbursement.

排除标准

  • Objective tinnitus;
  • Conductive HL;
  • Unstable medical history that limits participation;
  • Undergoing any other concurrent treatments on tinnitus or HL;
  • Having used HAs in the past 1 year;
  • Unwilling or unable to use HAs daily;
  • Alcohol or drug abuse;
  • Unable to read or write.

结局指标

主要结局

tinnitus handicap inventory (THI)

时间窗: 6 months from baseline

The THI is a self-administered test, including 25 questions with grades four categories of tinnitus severity: slight corresponding to a score of 0-16, mild (18-36), moderate (38-56), severe (58-100). The higher the score the more severe the tinnitus.

次要结局

  • the Hospital Anxiety and Depression Scale (HADs)(6 months from baseline)
  • speech recognition score (SRS) test(6 months from baseline)
  • pure tone audiometry (PTA)(6 months from baseline)
  • otoacoustic emission (OAE)(6 months from baseline)
  • the Athens Insomnia Scale-8 (AIS-8)(6 months from baseline)

研究者

申办方类型
Other
责任方
Sponsor

相似试验